Traded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 5, 2025 · Filed Nov 6, 2025
The CEO of Ventas sold $1.45M of Ventas shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,449,348
Shares × reported transaction price
7 days after results of Oct 29, 2025, 92 days before results of Feb 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $74.98 on Nov 5, 2025, at its 52-week high, after a 9% rise over the previous 30 trading days
52-week range $56.90 (Jan 6, 2025) to $74.98 (Nov 5, 2025), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $68.48 on Sep 24, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.5% | +0.1% | +2.4% |
| 30 days | +6.5% | +1.9% | +4.6% |
| 90 days | +5.0% | +1.0% | +4.0% |
| 180 days | +13.9% | +9.4% | +4.5% |
Past results only. Not a forecast.
Traded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Debra A Cafaro (Chairman and CEO) sold ~$831K of Ventas
Scheduled in advanceTraded Dec 1, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.